Clovis Oncology (CLVS) Tops Q1 EPS by 15c

Clovis Oncology (NASDAQ: CLVS) reported Q1 EPS of ($1.33), $0.15 better than the analyst estimate of ($1.48). Revenue for the quarter came in at $7.05 million versus the consensus estimate of $4.89 million.

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth